Globis Capital Partners

Globis Capital Partners

A venture capital firm in Japan that focuses on a combination of local businesses.

Globis Capital Partners is a venture capital firm in Japan that focuses on a combination of local businesses. Founded 1996 in Tokyo, Japan by Jun Hosoya, it invests in early stage ventures, late stage ventures, and seed. Its portfolio companies include Rentio, bellFace, FLYWHEEL Japan, minma, justInCase, SmartNews, AGRIMEDIA, AI Medical Service, OCT, and Andpad. As of April 2020, Globis Capital Partners has made 110 investments. Their most recent investment was on February 25, 2020, when Rentio raised ¥1B. Globis Capital Partners has had 13 exits, the most notable of which include Mercari, GREE, and Uzabase. Globis Capital Partners has raised six funds, their latest being Globis Fund VI. This fund was announced on April 18, 2019 and raised a total of ¥36B.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
AI Medical Service

An artificial intelligence and healthcare company making software for the early detection of gastrointestinal cancers.

Nanapi is a Tokyo-based company.

9 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Akihiro Ideguchi

Investment Team

Emre Yuasa

Principal

Kariya SonoSatoshiichi

Managing Partner

Satoshi Fukushima

Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

bellFace

FLYWHEEL Japan

justInCase

minma

Rentio

SmartNews

News

Title
Author
Date
Publisher
Description
Catherine Shu
October 4, 2019
TechCrunch
AI Medical Service, a Tokyo-based company developing AI-based software to help detect gastric cancer, announced today that it has raised a $42.9 million Series B. Investors include Globis Capital Partners, World Innovation Lab and Sony Innovation Fund by IGV. The funding will be used for clinical trials of its software, which looks for signs of [...]

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.